AXIM Biotechnologies Successfully Completes Point-of-Care Clinical Trials on its Rapid COVID-19 Neutralizing Antibody Test
AXIM has successfully completed point-of-care clinical trials on its ImmunoPass rapid test. (Credit: Pete Linforth from Pixabay)